Logotype for Gujarat Fluorochemicals Limited

Gujarat Fluorochemicals (FLUOROCHEM) Q4 24/25 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Gujarat Fluorochemicals Limited

Q4 24/25 earnings summary

18 Jun, 2026

Executive summary

  • Q4 FY2025 revenue from operations reached INR 1,225 crore, up 8% year-on-year, with EBITDA rising 28% to INR 305 crore and PAT nearly doubling to INR 191 crore; net debt reduced to INR 1,451 crore, improving net debt to equity from 0.3 to 0.2.

  • Growth was driven by the fluoropolymers vertical and a better product mix, while bulk chemicals underperformed due to a plant incident and softening prices.

  • Mechanical completion of the LFP plant achieved; LiPF6 salt production stabilized with capacity expansion underway.

  • Significant CapEx of INR 1,600 crore announced for FY2026, with INR 1,200 crore for EV battery materials and INR 400 crore for fluoropolymers and refrigerants.

  • Major restructuring completed, including wind business demerger and new subsidiaries for green and specialty chemicals.

Financial highlights

  • Q4 FY2025 consolidated revenue: INR 1,225 crore (up 8% YoY), EBITDA: INR 305 crore (up 28% YoY), PAT: INR 191 crore (up 89% YoY), with EBITDA margin at 25%.

  • Net debt reduced by over INR 300 crore year-over-year, with net debt to equity improving from 0.3 to 0.2.

  • Working capital days increased due to inventory build-up in anticipation of demand.

  • Power and fuel savings from captive plant expected to be INR 120–150 crore annually, with partial benefits in FY2026.

  • One-time reversal of deferred tax liability of INR 29 crore lowered tax rate in the quarter.

Outlook and guidance

  • Expecting 25% year-on-year growth in fluoropolymers, with continued momentum in core business.

  • EV battery materials business to see revenue ramp-up in H2 FY2026, with further acceleration in FY2027.

  • Refrigerant segment to grow, with R32 commercial sales targeted for H2 FY2026.

  • Bulk chemicals segment expected to normalize as plant resumes and prices stabilize.

  • Specialty chemicals expected to see improved margins and volumes in FY26.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more